Related Experiment Video
Updated: Jan 14, 2026

An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection
Published on: June 24, 2025
Do Aminopenicillins Have a Role in Treating Ampicillin-Resistant Enterococcus UTIs?
Armani M Hawes1, Pranita D Tamma2, Navaneeth Narayanan3,4
1Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Abstract:
Urinary tract infections caused by Enterococcus species are a frequent clinical challenge. The rising prevalence of ampicillin resistance often seemingly precludes the use of aminopenicillins. However, evidence suggests that aminopenicillins may retain clinical efficacy, even when susceptibility testing indicates resistance. Integrating available pharmacokinetics/pharmacodynamics and clinical data and risk-benefit considerations, we seek to address the question: Can aminopenicillins still be a viable treatment option in the management of ampicillin-resistant Enterococcus infections?
Insights
Aminopenicillins may remain effective for treating urinary tract infections caused by ampicillin-resistant Enterococcus species. This review integrates data to assess their continued viability in clinical practice.
Area of Science:
- Infectious Diseases
- Pharmacology
- Clinical Microbiology
Background:
- Urinary tract infections (UTIs) caused by Enterococcus species present a significant clinical challenge.
- Increasing ampicillin resistance in Enterococcus strains often leads to the exclusion of aminopenicillins from treatment regimens.
Purpose of the Study:
- To evaluate the potential clinical utility of aminopenicillins for treating ampicillin-resistant Enterococcus infections.
- To integrate pharmacokinetic/pharmacodynamic (PK/PD) data, clinical evidence, and risk-benefit analyses.
Main Methods:
- Review of existing pharmacokinetic/pharmacodynamic (PK/PD) data.
- Analysis of clinical studies and case reports.
- Assessment of risk-benefit profiles for aminopenicillin use.
Main Results:
- Emerging evidence suggests that aminopenicillins may retain clinical efficacy despite in vitro resistance.
- PK/PD parameters and clinical outcomes indicate a potential for successful treatment in select cases.
Conclusions:
- Aminopenicillins could still be a viable therapeutic option for ampicillin-resistant Enterococcus UTIs.
- Further clinical studies are warranted to define optimal usage and patient selection criteria.
More Related Videos
Related Concept Videos
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Acute Pyelonephritis II: Diagnostic Studies and Management
Urine Studies II: Urine Culture and Sensitivity Test
Estimation of k and VD of Aminoglycosides
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Development of Antibiotic Resistance

